However, there’s another side of the usage of this treatment that’s being discussed. Multiple Sclerosis News Today’s contributor blogger and multiple sclerosis (MS) patient, Ian Franks, questions the possible side effects of Zinbryta: “Would you agree to be treated with an MS disease-modifying therapy that has been developed to help you but has side effects that could, maybe only rarely but still could, lead to serious illness or even death?
Recently Biogen and AbbVie also announced that Zinbryta received marketing authorization by the European Commission.
In this MD Magazine TV video, listen to a brief introduction to Zinbryta from the month before its FDA approval.
Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.